Leukaemia Flashcards

1
Q

Neoplasm

A
  • abnormal new growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Benign tumour

A
  • remain localised, don’t metastasize
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Malignant tumour

A
  • metastasize through lymphatic channels or blood vessels to lymph nodes and other tissues in the body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Primary tumour

A
  • tumour growing at the anatomical site where tumour progression began and proceeded to yield this mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metastatic tumour

A
  • tumour forming at one site in body, cells (metastases) of

which derive from a tumour located elsewhere in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Carcinomas

A
  • constitute 90% of cancers

- cancers of epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sarcomas

A
  • rare and consist of tumours of connective tissues (connective tissue, muscle, bone etc.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Leukaemias and lymphomas

A
  • constitute 8% of tumours
  • aka liquid tumours
  • leukaemias arise from blood forming cells
  • lymphomas arise from cells of the immune system (T and B cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Proto-oncogenes

A
  • over 100
  • proteins that promote cell cycle
  • mutations lead to oncogenes, promote cell growth regardless of circumstances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tumour suppressor genes

A
  • proteins that inhibit cell cycle

- mutations lead to cell cycle not stopping even when it should (p53 and Rb genes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DNA repair genes and apoptosis genes

A
  • DNA repair genes repair any mutated genes

- apoptosis genes kill mutated genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Proto oncogenes that code for leukaemia

A
  • BCR-ABL (tyrosine kinase)

- MYC (transcription factor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tumour suppressor genes that codes for leukaemia

A
  • NF-1

- inhibitor of Ras, a protein that stimulates cell division

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Leukaemia vs Lymphoma

A
  • Leukaemia: neoplasm originates from haemopoietic stem cells in bone marrow w/widespread movement in peripherical blood
  • Lymphoma: neoplasm originates from lymphocytes, which are in lymph nodes, spleen, thymus and bone marrow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Symptoms of leukaemia

A
  • weight loss
  • fever
  • frequent infections
  • shortness of breath
  • muscular weakness
  • pain/tenderness in bones or joints
  • fatigue
  • loss of appetite
  • swelling of lymph nodes
  • spleen/liver enlargement
  • night sweats
  • easy bruising
  • purplish patches or sports
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Malignant haematopoiesis

A
  • cell of origin of leukaemia undergoes mutations
  • become leukaemia stem cells
  • block in differentiation causes them to divide and become blasts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Oncogenic drivers of granulocyte macrophage progenitor

A
  • MLL-ENL
  • MLL-AF9
  • MOZ-TIF2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Oncogenic drivers of common myeloid progenitor

A
  • MLL-ENL
  • MLL-AF9
  • MOZ-TIF2
  • MN1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Oncogenic drivers of common lymphoid progenitor

A
  • MLL-ENL

- MLL-AF9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Oncogenic drivers from haematopoietic stem cell

A
  • MLL-ENL
  • MLL-AF9
  • MOZ-TIF2
  • MN1
  • CALM-AF10
  • MLL-GAS7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

General mechanisms of leukemic transformation

A
  • impaired differentiation
  • increased cell survival
  • increased proliferation
  • increased self-renewal
  • genomic instability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Metastasis of leukaemia

A
  • Leukaemia-derived exosomes transfer pro-angiogenic molecules toward ECs
  • enhances angiogenesis through stimulating factors
  • Leukemic cells-derived exosomes cause metastasis
    to lymph nodes through blood circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Leukaemia clonal disorder

A
  • Haematological malignancies are clonal disorders

- the malignant cells all share the same basic genetic or molecular abnormalities

24
Q

Key genetic/biochemical steps in leukaemia (aetiology)

A
  • genetic mutation/oncogene activation leading to
  • increased proliferation rate
  • reduced apoptosis
  • block in differentiation
25
Physical, chemical and biological agents in activation of oncogenes or mutations
- heredity - chromosomal abnormalities - chemical agents/drugs e.g benzene - ionising radiation - viruses
26
Chromosomal abnormalities in leukaemia
- deletions: deletion of entire, or part of, a chromosome, therefore effect on cell function - inversions: rearrangement in which a segment of a chromosome is reversed - translocations: exchange of genetic material between chromosomes
27
Four main types of leukaemia
- acute lymphoblastic (lymphocytic) leukaemia (ALL) - acute myeloid (myelogenous) leukaemia (AML) - chronic lymphocytic leukaemia (CLL) - chronic myeloid leukaemia (CML)
28
Acute (ALL and AML) vs Chronic (CLL and CML) leukaemias
- acute: made of immature blast cells - ALL most common in children - AML most common in adults - chronic have no blast cells
29
General features of leukaemia
- most common neoplastic disease of white cells - 9 per 100,000 population - expansion of bone marrow + infiltration by neoplastic white cells is common - neoplastic proliferation of marrow cells forming one or more cell lines. - Circulation of neoplastic cells in peripheral blood in most cases. - Anaemia - Low platelets - Bone marrow appearance becomes ‘monotonous’ as it is replaced by abnormal cells
30
Acute leukaemias
- uncontrolled proliferation of poorly differentiated blast cells (>20%) - marrow replacement by blast cells causes anaemia, increase in infection, and an increased tendency towards bleeding. - Patients develop fever, malaise, bleeding and mouth ulcers due to infections. - increased white cell count (including blast cells) in about 50% of cases. Could also be normal or reduced • Diagnosis is based on the bone marrow aspirate. • frequently show infiltration of many organs, especially the brain
31
French-American-British (FAB) Scheme of Classification of AML (M0, M1, M2)
- M0 Undifferentiated - M1 AML without maturation - M2 AML with granulocytic maturation
32
French-American-British (FAB) Scheme of Classification of AML (M3, M4)
- M3 Acute promyelocytic leukaemia | - M4 Myelomonocytic leukaemia
33
French-American-British (FAB) Scheme of Classification of AML (M5, M6, M7)
- M5 Monoblastic or monocytic leukaemia - M6 Erythroleukaemia - M7 Megakaryocytic leukaemia
34
Auer rods
- large, crystalline cytoplasmic inclusion bodies
35
Bone marrow failure in acute leukaemias
- pallor and lethargy, due to reduction in erythropoiesis. - Fever, malaise, infections of the mouth, throat, skin and respiratory tract - due to the reduction in production of normal WBC’s. - Spontaneous bruising, purpura, bleeding gums etc, usually due to thrombocytopaenia.
36
Organ infiltration in acute leukaemias
- Bone pain. - Lymphadenopathy in ALL - Moderate splenomegaly and hepatomegaly, especially in ALL - Infiltration of the gums and skin is particularly seen in myelomonocytic (M4) and monocytic (M5) types
37
Lab findings in acute leukaemias
- Normochromic, normocytic anaemia - Total WBC count may be decreased or normal but it is often increased to >200 x 10^9 /l, with variable numbers of blast cells. - In AML the blast cells may contain Auer Rods. - Thrombocytopaenia is present in most acute leukaemias, and is marked in AML. - Hypercellularity of the bone marrow
38
Chloroacetate esterase in acute leukaemias
- leucocyte isoenzymes of esterases 1,2,7 and 8 can be stained using a-naphthyl AS-D chloroacetate. - main application of this stain is in the differentiation of granulocytic cell lines (CE positive) and monocytic cell lines (negative)
39
Peroxidase and Sudan Black B
- Peroxidase is for myeloperoxidase which is present in granulocyte and monocyte cell lines. • Sudan Black B stains neutral fats, phospholipids and lipoprotein and the reaction patterns are closely equivalent to the peroxidase reaction. - These stains are therefore most useful in distinguishing between ALL and AML (M1 - M6)
40
Non-specific esterase in acute leukaemias
- many substrates which can be used to identify and localise isoenzymes of esterases 3,4,5, and 6. - main use of this stain is to differentiate between granulocytic and monocytic cell lines. - monocytic cell lines are NSE positive
41
Acid phosphatase in acute leukaemias
- Acid phosphatase is present in lysosomes of haemopoietic cells. - The most significant application isthe classification of lymphoproliferative diseases. - In T- cell ALL the reaction is localised to an area of the cytoplasm which is occupied by the Golgi apparatus
42
Terminal deoxynucleotidyl transferase (TdT) in acute leukaemias
- TdT is a DNA polymerase activity which is present at high levels in lymphoid cells. - It is an early marker for B and T cell acute lymphoblastic leukaemia
43
Lysozyme in acute leukaemias
- Greatly increased levels of serum lysozyme are seen in monocytic leukaemias, with smaller increases seen in myeloblastic leukaemias
44
Immunological markers in acute leukaemias
- particularly used in identification of subgroups of ALL presence or absence of cell surface marker molecules. - The advent of McAbs has allowed identification of cells at varying stages of their differentiation
45
FAB classification of ALL
- L1 small, monomorphic - L2 large, heterogeneous - L3 Burkitt-cell type
46
Acute Lymphoblastic Leukaemia (ALL)
- Accumulation of lymphoblasts in bone marrow - Incidence of ALL is highest at 3–7 years - Some cases initiated by genetic mutations that occur during development in utero
47
Chronic leukaemias
- malignant cells are relatively well differentiated - Identifiable morphologically by the use of conventional Romanowski staining procedures. - 2 major classifications of chronic leukaemia are CML and CLL.
48
Chronic myeloid leukaemia (CML)
- aka chronic granulocytic leukaemia CGL. - malignant proliferation of granulocytes in bone marrow and other haemopoietic organs - characterised by the presence of a chromosomal marker, the Philadelphia (Ph) chromosome, in the haemopoietic cells
49
Philadelphia chromosome
- Translocation t(9;22)(q34;q11) - The Philadelphia chromosome is 22 - This is where the ABL-BCR (tyrosine kinase) fusion is
50
Incidence of CML
- 20% of all leukaemias - 1 per 100,000 population - between 20 and 60 years of age.
51
Clinical features of CML
- Anaemia: pallor, lethargy, especially in the later stages - Splenomegaly and hepatomegaly - former is almost always present and often massive, latter is fairly common. - Bleeding: haemorrhage or bruising is common, due to abnormal platelet function. - Hypermetabolism: an increase in the basal metabolic rate is common, resulting in fever, night sweats and weight loss. - Bone pain - hypercellularity of marrow. - Prolonged infections
52
Lab findings in CML
- Normochromic/normocytic anaemia - WBC count between 50-300 x10^9/l, but may be higher - A complete range of myeloid cells seen in the peripheral blood, majority of cells being myelocytes, metamyelocytes, band forms and mature neutrophils - A few myeloblasts and promyelocytes may be seen
53
Features in CML
- Thrombocytosis common in the early stages, platelet counts of >1000 x10^9/l may be reached - platelets are larger than normal and reduced function. - Hypercellularity of marrow, with many cells of granulocyte series. - most cases show increased level of LDH. Serum B12 levels may be up to 15x normal level, due to increased synthesis of transcobalmins I and III by leukaemic granulocytes. - Philadelphia Chromosome: Chromosomal analysis of haemopoietic cells reveals the Ph chromosome. - An abnormally small chromosome which results from translocation of a portion of the long arm of ch 22 to ch 9. This is considered as a diagnostic indicator of CML.
54
Incidence of CLL
- disease of the elderly, rare in patients <40 years old | - male:female ratio of 2:1
55
Clinical features of CLL
- Anaemia isn't an obvious symptom in most cases, especially in the early stages - About 10% of casesdevelop an haemolytic anaemia - Splenomegaly and hepatomegaly are common - Lymphadenopathy. - Bruising and purpura - due to thrombocytopaenia - Infections are common: bacterial, fungal, viral infections may present
56
Lab findings of CLL
- anaemia may be present later - 10% of cases develop autoimmunity. - Total WBC is >15 x 10^9/l and may be 300 x 10^9/l or higher. - Between 70-99% of cells are small mature lymphocytes. - Smear cells are common, fragile cells which are disrupted when making the blood film. - mature cells are B-cells in 90% of cases. - relatively rare T-CLL tends to be much more aggressive - Thrombocytopaenia - usually in later stages - bone marrow biopsy isn't usually required for diagnosis, marrow is 30-50% infiltrated by lymphocytes.